TEN Holdings, Inc. (XHLD) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, filed on February 21, 2025, reports on events occurring between February 12 and February 18, 2025. TEN Holdings, Inc., a Nevada corporation, successfully completed its Initial Public Offering (IPO) and commenced trading on The Nasdaq Capital Market under the ticker symbol "XHLD".
Key Financial Metrics and Transaction Details
- Shares Offered: 1,667,000 shares of Common Stock.
- Offering Price: $6.00 per share.
- Underwriting Basis: Firm commitment.
- Representative's Warrants: 83,350 warrants issued to the underwriters (Bancroft Capital, LLC) and affiliates.
- Warrant Exercise Price: $7.20 per share (120% of the public offering price).
- Warrant Term: Five-year period from the commencement of sales.
- Trading Commencement: February 13, 2025.
The filing text does not provide specific values for total gross proceeds, underwriting discounts, net proceeds, or the company's historical revenue, profit, cash flow, or debt levels.
Material Changes
The primary material change is the transition from a private entity to a publicly traded company. The company entered into a definitive underwriting agreement on February 12, 2025, and closed the transaction on February 18, 2025, following the SEC's declaration of effectiveness for the Form S-1 registration statement on February 7, 2025.
Guidance, Outlook, and Risks
This filing focuses on the execution of the IPO and does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard legal disclaimers regarding the offer of securities. The company is designated as an emerging growth company.
Investor Verification Checklist
- Verify the final number of shares sold and total gross proceeds in the final prospectus or Form 424B5.
- Confirm the specific underwriting discount percentage and total fees paid to Bancroft Capital, LLC.
- Review the full Underwriting Agreement (Exhibit 10.1) for lock-up periods and indemnification terms.
- Examine the Representative's Warrants (Exhibit 4.1) for specific exercise conditions and potential dilution impact.
- Check the company's audited financial statements in the effective Form S-1 for historical revenue, margins, and liquidity positions.